Impact of Delayed Video-Assisted Thoracoscopic Surgery on Pneumonectomy Outcomes in Patients with Tuberculosis
https://doi.org/10.35401/2541-9897-2025-10-2-24-32
Abstract
Objective: To investigate the impact of delayed video-assisted thoracoscopic surgery (VATS) on the rate of postoperative complications and tuberculosis recurrence following pneumonectomy.
Materials and methods: A retrospective, open, cohort, nonrandomized, multicenter study conducted between 1984 and 2022 included 815 patients with destructive pulmonary tuberculosis who underwent pneumonectomy with delayed VATS thoracoplasty (group 1, 214 patients) or without it (group 2, 601 patients). Both groups were further divided into 3 subgroups based on multislice computed tomography findings of the remaining lung condition: А, no pathology; Б, foci or tuberculoma without cavitation; В, cavitation (CV+).
Results: In group 1, postoperative complications occurred in 7 patients (3.27%); there was no hospital mortality, and the short-term effectiveness of the surgery was 95.79% (205 patients). In group 2, these parameters were 28.95%, 7.49%, and 85.36%, respectively. In group 1, the effectiveness at 1, 3, and 5 years after discharge was 98.54%, 95.51%, and 93.20%, respectively; 32 (15.53%) patients had recurrence or progression of tuberculosis. Eight patients (3.88%) died from tuberculosis, and 11 (5.24%) experienced late bronchopleural complications. The 5-year survival rate for group 1 was 93.96%. The long-term outcomes in group 2 were worse. The effectiveness at 1, 3, and 5 years was 91.33%, 89.81%, and 87.28%, respectively. Recurrence or progression of tuberculosis was observed in 74 patients (18.88%); 34 patients died from tuberculosis (8.67%), and 42 patients had late bronchopleural complications (10.71%). The 5-year survival rate was 85.52%.
Conclusions: Delayed VATS thoracoplasty significantly improves both short-term and long-term outcomes of pneumonectomy in patients with tuberculosis, especially in case of a destructive process affecting the remaining lung.
About the Authors
D. B. GillerRussian Federation
Dmitry B. Giller - Dr. Sci. (Med.), Professor, Head of the M.I. Perelman Department of Phthisiopulmonology and Thoracic Surgery, N.V. Sklifosovskiy Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University.
ulitsa Trubetskaya 8/2, Moscow, 119435
V. A. Basangova
Russian Federation
Valeriia A. Basangova - Assistant Professor at the M.I. Perelman Department of Phthisiopulmonology and Thoracic Surgery, N.V. Sklifosovskiy Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University.
Moscow
O. Sh. Kesaev
Russian Federation
Oleg Sh. Kesaev - Dr. Sci. (Med.), Professor at the M.I. Perelman Department of Phthisiopulmonology and Thoracic Surgery, N.V. Sklifosovskiy Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University.
Moscow
S. S. Saenko
Russian Federation
Sergey S. Saenko - Cand. Sci. (Med.), Thoracic Surgeon, Head of the Lung Surgery Unit, Regional Clinical Center of Phthisiopulmonology.
Rostov-on-Don
Sh. E. Mayusupov
Uzbekistan
Shokirjon E. Mayusupov - Thoracic Surgeon, Head of the Lung Surgery Unit, Republican Specialized Scientific and Practical Medical Center for Phthisiology and Pulmonology.
Tashkent
B. I. Nasritdinov
Uzbekistan
Bobir I. Nasritdinov - Thoracic Surgeon, Republican Specialized Scientific and Practical Medical Center for Phthisiology and Pulmonology.
Tashkent
E. F. Ermakov
Uzbekistan
Eler F. Ermakov - Thoracic Surgeon, Republican Specialized Scientific and Practical Medical Center for Phthisiology and Pulmonology.
Tashkent
M. S. Shogenov
Russian Federation
Murat S. Shogenov - Cand. Sci. (Med.), Oncologist, Thoracoabdominal Surgeon, Central Tuberculosis Research Institute.
Moscow
E. V. Glukhov
Russian Federation
Evgeny V. Glukhov - Cand. Sci. (Med.), Oncologist, Abdominal Surgeon, Central Tuberculosis Research Institute.
Moscow
A. A. Filatov
Russian Federation
Anton A. Filatov - Cand. Sci. (Med.), Oncologist, Thoracoabdominal Surgeon, Central Tuberculosis Research Institute.
Moscow
I. A. Dadyev
Russian Federation
Islam A. Dadyev - Cand. Sci. (Med.), Oncologist, Abdominal Surgeon, Central Tuberculosis Research Institute.
Moscow
A. E. Ergeshov
Russian Federation
Atadzhan E. Ergeshov - Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences, Director, Central Tuberculosis Research Institute.
Moscow
References
1. Perelman MI, Ots ON, Agkatsev TV. Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs. Consilium Medicum. 2011;13(3):5–10. (In Russ.).
2. Giller DB, Giller GV, Tokaev KV, et al, inventors; GOU DPO RMAPO Roszdrava, TsNIIT RAMN, assignees. Method of preventing post-pneumonectomic syndrome. Russian Patent RU2428942C1. September 20, 2011.
3. Bribriesco A, Patterson GA. Management of postpneumonectomy bronchopleural fistula: from thoracoplasty to transsternal closure. Thorac Surg Clin. 2018;28(3):323–335. PMID: 30054070. https://doi.org/10.1016/j.thorsurg.2018.05.008
4. Kariev TM, Babadzhanova NA. Pneumonectomy in disseminated fibrous-cavernous tuberculosis. Probl Tuberk. 2000;(4):27–28. (In Russ.). PMID: 10981428.
5. Shiraishi Y, Nakajima Y, Koyama A, Takasuna K, Katsuragi N, Yoshida S. Morbidity and mortality after 94 extrapleural pneumonectomies for empyema. Ann Thorac Surg. 2000;70(4):1202–1207. PMID: 11081871. https://doi.org/10.1016/s0003-4975(00)01612-x
6. Repin YuM. Surgical treatment strategy for patients with drug-resistant pulmonary tuberculosis. Russian Journal of Thoracic and Cardiovascular Surgery. 2001;(1):46–51. (In Russ.).
7. Kariev TM, Sabirov ShIu. Removing of the remaining parts of the lung by the pulmonectomy type in tuberculosis reactivation after partial resect ions. Probl Tuberk. 2002;(6):37–39. (In Russ.). PMID: 12227048.
8. Frolov GA, Popkova NL, Kalashnikov AV. Results of surgical treatment in patients with drug-resistant tuberculosis. Probl Tuberk. 2002;(7):15–18. (In Russ.). PMID: 12561634.
9. Grishchenko NG, Krasnov VA, Andrenko AA, et al. Role of surgical treatments in patients with fibrocavernous pulmonary tuberculosis. Probl Tuberk. 2003;(2):36–38. (In Russ.). PMID: 12790032.
10. Erimbetov KD. Enhancing the efficiency of treatment in patients with multidrug resistant pulmonary tuberculosis by a combination of surgery and adequate chemotherapy. Probl Tuberk Bolezn Legk. 2003;(4):39–41. (In Russ.). PMID: 12774419.
11. Kim YT, Kim HK, Sung SW, Kim JH. Long-term outcomes and risk factor analysis after pneumonectomy for active and sequela forms of pulmonary tuberculosis. Eur J Cardiothorac Surg. 2003;23(5):833–839. PMID: 12754042. https://doi.org/10.1016/s1010-7940(03)00031-9
12. El’kin AV, Repin IuM, Levashev IuN. Surgical treatment for postoperative recurrent pulmonary tuberculosis. Probl Tuberk Bolezn Legk. 2004;(2):28–32. (In Russ.). PMID: 15137125.
13. El’kin AV, Repin IuM, Levashev IuN. Outcomes of surgical treatment of patients with progressive pulmonary tuberculosis an concomitant diseases. Probl Tuberk Bolezn Legk. 2005;(11):22–25. (In Russ.). PMID: 16405088.
14. Sherwood JT, Mitchell JD, Pomerantz M. Completion pneumonectomy for chronic mycobacterial disease. J Thorac Cardiovasc Surg. 2005;129(6):1258–1265. PMID: 15942565. https://doi.org/10.1016/j.jtcvs.2004.12.053
15. Garifullin ZR, Aminev KhK. Efficiency of surgical treatment in patients with drug-resistant pulmonary tuberculosis in relation to the course of a disease. Tuberk Biolezni Legkih. 2009;(7):41–46. (In Russ.). PMID: 19697856.
16. Ots ON, Agkatsev TV, Perel’man MI. Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs. Probl Tuberk Bolezn Legk. 2009;(2):42–49. (In Russ.). PMID: 19382642.
17. Sabirov ShIu. Surgical treatment for destructive pulmonary tuberculosis complicated by spontaneous pneumothorax and pleural empyema. Tuberk Biolezni Legkih. 2009;(8):31–33. (In Russ.). PMID: 19803348.
18. Shiraishi Y, Katsuragi N, Kita H, Tominaga Y, Kariatsumari K, Onda T. Aggressive surgical treatment of multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg. 2009;138(5):1180–1184. PMID:19837220. https://doi.org/10.1016/j.jtcvs.2009.07.018
19. Kang MW, Kim HK, Choi YS, et al. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg. 2010;89(5):1597–1602. PMID: 20417785. https://doi.org/10.1016/j.athoracsur.2010.02.020
20. Papiashvili M, Barmd I, Sasson L, et al. Pulmonary resection for multidrug-resistant tuberculosis: the Israeli experience (1998-2011). Isr Med Assoc J. 2012;14(12):733–736. PMID: 23393710.
21. Hu XF, Duan L, Jiang GN, Wang H, Liu HC, Chen C. Risk factors for early postoperative complications after pneumonectomy for benign lung disease. Ann Thorac Surg. 2013;95(6):1899–1904. PMID: 23642434. https://doi.org/10.1016/j.athoracsur.2013.03.051
22. Skornyakov SN, Motus IYa, Kildyusheva EI, Medvinsky ID, Bazhenov AV, Savelyev AV. Surgery for drug-resistant destructive pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2015;(3):15–21. (In Russ.).
23. Razakov OR, Batirov RR. Evaluation of the results of 70 pulmonectomies produced due to complicated destructive pulmonary tuberculosis. Nauka, novye tekhnologii i innovatsii Kyrgyzstana. 2017;(8):83–85. (In Russ.).
24. Marfina GY, Vladimirov KB, Avetisian AO, et al. Bilateral cavitary multidrug- or extensively drug-resistant tuberculosis: role of surgery. Eur J Cardiothorac Surg. 2018;53(3):618–624. PMID: 29040413. https://doi.org/10.1093/ejcts/ezx350
Review
For citations:
Giller D.B., Basangova V.A., Kesaev O.Sh., Saenko S.S., Mayusupov Sh.E., Nasritdinov B.I., Ermakov E.F., Shogenov M.S., Glukhov E.V., Filatov A.A., Dadyev I.A., Ergeshov A.E. Impact of Delayed Video-Assisted Thoracoscopic Surgery on Pneumonectomy Outcomes in Patients with Tuberculosis. Innovative Medicine of Kuban. 2025;10(2):24-32. (In Russ.) https://doi.org/10.35401/2541-9897-2025-10-2-24-32